Journal of cardiothoracic and vascular anesthesia
-
J. Cardiothorac. Vasc. Anesth. · Dec 1999
Randomized Controlled Trial Clinical TrialA randomized, blinded trial of the antioxidant pegorgotein: no reduction in neuropsychological deficits, inotropic drug support, or myocardial ischemia after coronary artery bypass surgery.
To determine whether patients receiving pegorgotein preoperatively would be less likely than patients receiving placebo to demonstrate postoperative cerebral or myocardial dysfunction and thus would be less likely to (1) demonstrate a decline in neuropsychologic testing after cardiopulmonary bypass, (2) receive inotropic drug support, or (3) demonstrate electrocardiographic signs of ischemia or infarction. ⋯ This study showed no positive influence of pegorgotein on the incidence of any of the findings and showed a trend toward an increased incidence of myocardial ischemia or infarction.
-
J. Cardiothorac. Vasc. Anesth. · Dec 1999
Letter Case ReportsPostoperative delirium and defibrillation.
-
J. Cardiothorac. Vasc. Anesth. · Oct 1999
Randomized Controlled Trial Comparative Study Clinical TrialRocuronium versus vecuronium during fentanyl induction in patients undergoing coronary artery surgery.
To evaluate the neuromuscular, ventilatory, and cardiovascular effects of rocuronium and vecuronium. ⋯ During narcotic induction of anesthesia, rocuronium was associated with lower requirement for vasopressors, faster onset of neuromuscular blockade, and better conditions for mask ventilation and tracheal intubation compared with vecuronium.